Open AccessCalcium gluconate infusion is as effective as the vascular endothelial growth factor antagonist cabergoline for the prevention of ovarian hyperstimulation syndrome
Author(s) -
Nikita Naredi,
Sandeep Karunakaran
Publication year - 2013
Publication title -
journal of human reproductive sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.484
H-Index - 31
eISSN - 0974-1208
pISSN - 1998-4766
DOI - 10.4103/0974-1208.126293
Subject(s) - cabergoline , ovarian hyperstimulation syndrome , medicine , dopamine agonist , inclusion and exclusion criteria , agonist , ovulation , pregnancy , anesthesia , gynecology , in vitro fertilisation , hormone , prolactin , biology , receptor , genetics , alternative medicine , pathology
Ovarian hyperstimulation syndrome (OHSS) is an iatrogenic and potentially life-threatening disease process, which may occur in healthy young women undergoing controlled ovarian hyperstimulation for assisted reproduction. As the treatment is largely empirical, prevention forms the mainstay of management.